Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01174095 · ClinicalTrials.gov registry record
Post Ten Year Follow up Assessment of a Phase I Trial of Angiogenic Gene Therapy
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 31
- Enrollment target
NCT01174095: Completed study, sponsored by Weill Medical College of Cornell University.
NCT01174095 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01174095 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
Study Summary
The primary aim of the study is to assess and follow-up subjects that received AdGVVEGF121cDNA in IRB protocol #0794-894 entitled "Phase I Study of Direct Administration of a Replication Deficient Adenovirus Vector (AdGVVEGF121.10) Containing the VEGF121 cDNA to the Ischemic Myocardium of Individuals with Diffuse Coronary Artery Disease" and IRB protocol #0297-693 entitled "Phase I Study of Direct Administration of a Replication Deficient Adenovirus Vector (AdGVVEGF121.10) Containing the VEGF121 cDNA to the Ischemic Myocardium of Individuals with Diffuse Coronary Artery Disease Via Minimally Invasive Surgery".
Primary Outcome
The Canadian Cardiovascular Society Angina Score will be graded as: Grade I Stable angina develops upon strenuous, rapid, and/or prolonged exertion during work or recreation but is not induced by ordinary physical activity.. Grade II Stable angina is characterized by a slight limitation of ordinary activity and is induced by: Walking uphill or climbing stairs rapidly Walking or stair-climbing after meals Walking more than two level blocks or climbing more than one flight of ordinary stairs a
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2009-05 |
| Est. Completion | 2012-05 |
What the finished NCT01174095 record still lists
NCT01174095 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 31 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01174095 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01174095 about?
NCT01174095 is a clinical study titled "Post Ten Year Follow up Assessment of a Phase I Trial of Angiogenic Gene Therapy". The primary aim of the study is to assess and follow-up subjects that received AdGVVEGF121cDNA in IRB protocol #0794-894 entitled "Phase I Study of Direct Administration of a Replication Deficient Adenovirus Vector (AdGVVEGF121.10) Containing the VEGF121 cDNA to the Ischemic Myocardium of Individual...
What is the current status of trial NCT01174095?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2009-05. Estimated completion is 2012-05.
Who is sponsoring clinical trial NCT01174095?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia